Selected article for: "antiviral activity and RSV respiratory syncytial virus"
Author: Shigeta, Shiro; Mori, Shuichi; Yamase, Toshihiro; Yamamoto, Norio; Yamamoto, Naoki
Title: Anti-RNA virus activity of polyoxometalates
  • Cord-id: siyyve9e
  • Document date: 2006_5_24
    • ID: siyyve9e
    Snippet: The anti-RNA virus activity of polyoxometalates (POM) is reviewed, with a special emphasis on the anti-respiratory virus activities. There are many causative agents of acute viral respiratory infections; and it is rather difficult to identify the relevant agent in a given case by rapid clinical means. During acute progress of infection before the definitive diagnosis is obtained physicians need to prescribe certain broad spectrum anti-viral drugs. A titanium containing polyoxotungstate, PM-523 e
    Document: The anti-RNA virus activity of polyoxometalates (POM) is reviewed, with a special emphasis on the anti-respiratory virus activities. There are many causative agents of acute viral respiratory infections; and it is rather difficult to identify the relevant agent in a given case by rapid clinical means. During acute progress of infection before the definitive diagnosis is obtained physicians need to prescribe certain broad spectrum anti-viral drugs. A titanium containing polyoxotungstate, PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV) activities in vitro. Therapeutic effect of FluV A infected mice with aerosol inhalation of PM-523 was proven. A vanadium substituted polyoxotungstate, PM-1001 has antiviral activity against FluV A, RSV, parainfluenza virus (PfluV) type 2, Dengue fiver virus, HIV-1 and SARS coronavirus in vitro. Thus, POMs have been proven to be broad spectrum and non-toxic anti-RNA virus agents in both in vitro and in vivo experiments and are promising candidates for first-line therapeutics in acute respiratory diseases.

    Search related documents:
    Co phrase search for related documents
    • action antiviral mechanism and acute sars respiratory syndrome: 1, 2, 3, 4, 5
    • action antiviral mechanism and acute viral respiratory infection: 1
    • action mechanism and acute respiratory disease virus: 1, 2, 3
    • action mechanism and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • action mechanism and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mechanism and acute viral respiratory infection: 1, 2, 3
    • active target and acute respiratory infection: 1
    • active target and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • activity display and acute respiratory infection: 1, 2
    • activity display and acute sars respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8